World Trade Factory™

Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial

Terns Pharmaceuticals (TERN) Climbs 53% on Stellar Leukemia Treatment Trial

We recently published 10 Stocks Delivering Explosive 18-190% Gains. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the last week’s heavy gainers. Terns Pharmaceuticals soared by 53 percent in just the past five trading days of the week, primarily buoyed by encouraging results from its therapy candidate for chronic myeloid leukemia (CML). In an updated report [...]

Read Full Article →

📱 Tip: Tap the 🔗 Share icon in Safari and choose Add to Home Screen to install World Trade Factory.